Saturday, January 05, 2019 3:09:02 PM
Dec 2015
July-August of 2016
March-July 2017 around $6
Settlement Date Short Interest Avg Daily Share Volume Days To Cover
12/14/2018 5,542,513 186,519 29.715541
11/30/2018 5,542,897 150,113 36.924830
11/15/2018 5,744,717 160,815 35.722520
10/31/2018 5,783,150 426,886 13.547294
10/15/2018 5,553,619 220,507 25.185681
9/28/2018 5,765,630 363,517 15.860689
9/14/2018 5,689,444 180,832 31.462595
8/31/2018 5,740,454 183,845 31.224423
8/15/2018 5,814,264 287,331 20.235422
7/31/2018 5,619,190 323,299 17.380784
7/13/2018 5,512,714 1,629,466 3.383141
6/29/2018 4,987,450 1,045,374 4.770972
6/29/2018 4,987,450 1,045,374 4.770972
6/15/2018 6,160,104 1,074,516 5.732910
5/31/2018 6,081,254 277,243 21.934743
5/15/2018 5,979,269 251,146 23.807940
4/30/2018 5,876,481 325,520 18.052596
4/13/2018 5,287,123 272,186 19.424669
3/29/2018 5,019,020 281,431 17.833927
3/15/2018 4,609,105 317,430 14.520067
2/28/2018 4,388,774 211,082 20.791797
2/15/2018 4,555,968 380,550 11.972061
1/31/2018 4,404,075 356,538 12.352330
1/12/2018 4,409,183 228,264 19.316156
12/29/2017 4,276,431 377,630 11.324394
12/15/2017 4,304,432 370,493 11.618120
11/30/2017 3,947,232 238,331 16.561975
11/15/2017 4,130,255 336,051 12.290560
10/31/2017 3,968,208 393,658 10.080344
10/13/2017 4,124,416 322,079 12.805604
9/29/2017 4,190,896 328,327 12.764396
9/15/2017 5,242,635 317,674 16.503192
8/31/2017 5,239,000 257,228 20.367145
8/15/2017 5,194,724 314,850 16.499044
7/31/2017 4,976,655 447,648 11.117340
7/14/2017 5,246,665 200,255 26.199920
6/30/2017 5,426,328 349,228 15.538067
6/15/2017 5,352,771 366,357 14.610806
5/31/2017 5,496,064 254,238 21.617791
5/15/2017 5,705,235 257,722 22.137167
4/28/2017 5,743,508 298,960 19.211627
4/13/2017 6,097,676 509,261 11.973577
3/31/2017 6,122,257 437,604 13.990405
3/15/2017 6,008,738 496,050 12.113170
2/28/2017 5,977,265 958,014 6.239225
2/15/2017 5,550,290 1,194,724 4.645667
1/31/2017 5,642,103 390,023 14.466078
1/13/2017 5,993,005 362,871 16.515525
12/30/2016 6,155,442 543,620 11.323060
12/15/2016 6,135,007 1,350,344 4.543292
11/30/2016 5,453,862 1,314,075 4.150343
11/15/2016 4,994,424 462,347 10.802328
10/31/2016 5,126,490 467,389 10.968358
10/14/2016 5,641,528 1,330,709 4.239490
9/30/2016 4,757,807 4,507,562 1.055517
9/15/2016 3,882,966 550,887 7.048571
8/31/2016 3,592,230 430,557 8.343216
8/15/2016 3,922,013 1,381,348 2.839265
7/29/2016 4,599,225 2,577,268 1.784535
7/15/2016 4,315,354 1,330,585 3.243201
6/30/2016 4,207,730 894,768 4.702593
6/15/2016 3,154,365 367,715 8.578288
5/31/2016 3,678,916 373,466 9.850739
5/13/2016 3,222,127 694,950 4.636488
4/29/2016 3,270,522 1,329,977 2.459082
4/15/2016 2,938,786 1,441,302 2.038980
3/31/2016 2,790,941 387,570 7.201128
3/15/2016 3,275,303 786,528 4.164255
2/29/2016 3,351,869 517,311 6.479408
2/12/2016 3,296,512 1,167,248 2.824174
1/29/2016 2,970,306 828,118 3.586815
1/15/2016 3,167,934 2,532,059 1.251130
12/31/2015 2,735,608 2,441,362 1.120525
12/15/2015 3,154,419 2,304,913 1.368563
11/30/2015 2,644,088 8,471,719 1.000000
11/13/2015 2,303,738 7,321,149 1.000000
10/30/2015 2,085,698 1,219,686 1.710029
Read more: http://www.nasdaq.com/symbol/avxl/short-interest#ixzz4Uw6pLhSi
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM